Skip to content
2000
image of Evaluation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer through Shear-Wave Elastography

Abstract

Background:

There remains a lack of methods to accurately assess the efficacy of neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Objective:

This study aimed to investigate the value of shear-wave elastography in evaluating the treatment response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Materials and Methods:

This prospective observational study enrolled 275 patients with locally advanced rectal cancer who received neoadjuvant chemoradiotherapy during September 2021–March 2023. All patients underwent endorectal ultrasound and shear-wave elastography examination before total mesorectal excision. Clinical baseline data, endorectal ultrasound, and shear-wave elastography examination data were collected from all patients. The independent predictors of complete response were analyzed and screened, followed by the establishment of a logistic regression model. The diagnostic efficacy of the model was compared with that of radiologists.

Results:

The results of binary multivariate logistic regression suggested that the mean elastography value of the tumor lesion acted as an independent predictor for the diagnosis of complete response [OR: 0.894 (0.816, 0.981)]. The optimal cutoff value was 14.6 kPa. The area under the receiver operating characteristic curve of the model for predicting complete response in the training and test cohorts was 0.850 and 0.824, respectively. The diagnostic accuracy of the model was significantly higher than that of radiologists (P < 0.001).

Conclusion:

Shear-wave elastography can be used as a feasible method to evaluate the complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056327323250108055841
2025-03-17
2025-04-02
The full text of this item is not currently available.

References

  1. Sung H. Ferlay J. Siegel R.L. Laversanne M. Soerjomataram I. Jemal A. Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021 71 3 209 249 10.3322/caac.21660 33538338
    [Google Scholar]
  2. NCCN Guidelines. 2022 Available from: https://www.nccn.org/guidelines/category_1
  3. Vogel J.D. Felder S.I. Bhama A.R. Hawkins A.T. Langenfeld S.J. Shaffer V.O. Thorsen A.J. Weiser M.R. Chang G.J. Lightner A.L. Feingold D.L. Paquette I.M. The American society of colon and rectal surgeons clinical practice guidelines for the management of colon cancer. Dis. Colon Rectum 2022 65 2 148 177 10.1097/DCR.0000000000002323 34775402
    [Google Scholar]
  4. Glynne-Jones R. Wyrwicz L. Tiret E. Brown G. Rödel C. Cervantes A. Arnold D. ESMO Guidelines Committee Corrections to “rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up”. Ann. Oncol. 2018 29 Suppl. 4 iv263 10.1093/annonc/mdy161 29741565
    [Google Scholar]
  5. Loughrey M.B. Quirke P. Shepherd N.A. Standards and datasets for reporting cancers Dataset for histopathological reporting of colorectal cancer April 2023. 2023 Available from: https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html
  6. Li J. Huang X. Gao P. Song Y. Chen X. Lv X. Fu Y. Xiao Q. Ye S. Wang Z. Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data. BMC Cancer 2021 21 1 1214 10.1186/s12885‑021‑08922‑1 34773999
    [Google Scholar]
  7. Chen H.Y. Feng L.L. Li M. Ju H.Q. Ding Y. Lan M. Song S.M. Han W.D. Yu L. Wei M.B. Pang X.L. He F. Liu S. Zheng J. Ma Y. Lin C.Y. Lan P. Huang M.J. Zou Y.F. Yang Z.L. Wang T. Lang J.Y. Orangio G.R. Poylin V. Ajani J.A. Wang W.H. Wan X.B. College of American pathologists tumor regression grading system for long-term outcome in patients with locally advanced rectal cancer. Oncologist 2021 26 5 e780 e793 10.1002/onco.13707 33543577
    [Google Scholar]
  8. Nagtegaal I.D. Glynne-Jones R. How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement. Cancer Treat. Rev. 2020 84 101964 10.1016/j.ctrv.2020.101964 32000055
    [Google Scholar]
  9. Kim J.Y. Park I.J. Hong S.M. Lee J.L. Yoon Y.S. Kim C.W. Lim S.B. Lee J.B. Yu C.S. Kim J.C. Is pathologic near-total regression an appropriate indicator of a good response to preoperative chemoradiotherapy based on oncologic outcome of disease? Medicine 2015 94 50 e2257 10.1097/MD.0000000000002257 26683945
    [Google Scholar]
  10. Vailati B.B. São Julião G.P. Habr-Gama A. Perez R.O. Nonoperative management of rectal cancer. Surg. Oncol. Clin. N. Am. 2022 31 2 171 182 10.1016/j.soc.2021.11.003 35351272
    [Google Scholar]
  11. Grotenhuis B.A. Beets G.L. Watch-and-wait is an option in rectal cancer patients: From controversy to common clinical practice. Clin. Oncol. (R. Coll. Radiol.) 2023 35 2 124 129 10.1016/j.clon.2022.11.011 36481218
    [Google Scholar]
  12. Cong Y. Fan Z. Dai Y. Zhang Z. Yan K. Application value of shear wave elastography in the evaluation of tumor downstaging for locally advanced rectal cancer after neoadjuvant chemoradiotherapy. J. Ultrasound Med. 2021 40 1 81 89 10.1002/jum.15378 32648968
    [Google Scholar]
  13. Cote A. Florin F.G. Mois E. Elisei R. Badea R. Mare C. Hajjar N.A. Iancu C. Lebovici A. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy. Ann. Ital. Chir. 2018 89 2 168 176 29848812
    [Google Scholar]
  14. B. Amin Mahul AJCC Cancer Staging Manual Springer New York 2017 263 264 2017
    [Google Scholar]
  15. Dayde D. Tanaka I. Jain R. Tai M. Taguchi A. Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer. Int. J. Mol. Sci. 2017 18 3 573 10.3390/ijms18030573 28272347
    [Google Scholar]
  16. Zhao J.Y. Tang Q.Q. Luo Y.T. Wang S.M. Zhu X.R. Wang X.Y. Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy. World J. Gastrointest. Oncol. 2022 14 10 2014 2024 10.4251/wjgo.v14.i10.2014 36310703
    [Google Scholar]
  17. Shan J. Gu B. Shi L. Wang X. Ye W. Zhou W. Sun X. Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy. Transl. Cancer Res. 2021 10 1 88 98 10.21037/tcr‑20‑2269 35116242
    [Google Scholar]
  18. Cai Z. Huang L. Chen Y. Xie X. Zou Y. Lan P. Wu X. CEA decline predicts tumor regression and prognosis in locally advanced rectal cancer patients with elevated baseline CEA. J. Cancer 2020 11 22 6565 6570 10.7150/jca.49252 33046977
    [Google Scholar]
  19. Maier A.M. Heil J. Harcos A. Sinn H.P. Rauch G. Uhlmann L. Gomez C. Stieber A. Funk A. Barr R.G. Hennigs A. Riedel F. Schäfgen B. Hug S. Marmé F. Sohn C. Golatta M. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine? Eur. J. Radiol. 2020 128 109025 10.1016/j.ejrad.2020.109025 32371182
    [Google Scholar]
  20. Evans A. Sim Y.T. Pourreyron C. Thompson A. Jordan L. Fleming D. Purdie C. Macaskill J. Vinnicombe S. Pharoah P. Pre-operative stromal stiffness measured by shear wave elastography is independently associated with breast cancer-specific survival. Breast Cancer Res. Treat. 2018 171 2 383 389 10.1007/s10549‑018‑4836‑5 29858751
    [Google Scholar]
  21. Rubio I.T. Sobrido C. Neoadjuvant approach in patients with early breast cancer: Patient assessment, staging, and planning. Breast 2022 62 Suppl 1 Suppl. 1 S17 S24 10.1016/j.breast.2021.12.019 34996668
    [Google Scholar]
  22. Evans A. Sim Y.T. Lawson B. Macaskill J. Jordan L. Thompson A. The value of prognostic ultrasound features of breast cancer in different molecular subtypes with a focus on triple negative disease. Breast Cancer 2022 29 2 296 301 10.1007/s12282‑021‑01311‑3 34780035
    [Google Scholar]
  23. Qian Q. Zhuo M. Chen X. Shear-wave elastography predicts T-restaging and pathologic complete response of rectal cancer post neoadjuvant chemoradiotherapy. Abdom. Radiol. 2024 49 2561 2573 10.1007/s00261‑024‑04361‑1 38806703
    [Google Scholar]
  24. Zhang J. Tan X. Zhang X. Kang Y. Li J. Ren W. Ma Y. Efficacy of shear-wave elastography versus dynamic optical breast imaging for predicting the pathological response to neoadjuvant chemotherapy in breast cancer. Eur. J. Radiol. 2020 129 109098 10.1016/j.ejrad.2020.109098 32559591
    [Google Scholar]
  25. Ma Y. Zhang S. Zang L. Li J. Li J. Kang Y. Ren W. Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer. Eur. J. Cancer 2016 69 86 101 10.1016/j.ejca.2016.09.031 27821323
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056327323250108055841
Loading
/content/journals/cmir/10.2174/0115734056327323250108055841
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test